SCIACOVELLI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 6.968
AS - Asia 3.240
EU - Europa 2.538
AF - Africa 651
SA - Sud America 632
Continente sconosciuto - Info sul continente non disponibili 91
OC - Oceania 61
Totale 14.181
Nazione #
US - Stati Uniti d'America 6.607
IT - Italia 1.185
SG - Singapore 1.068
CN - Cina 584
BR - Brasile 396
VN - Vietnam 349
HK - Hong Kong 287
PL - Polonia 174
FR - Francia 143
BD - Bangladesh 119
DE - Germania 105
FI - Finlandia 104
SE - Svezia 100
IN - India 99
RU - Federazione Russa 87
NL - Olanda 85
GB - Regno Unito 70
CA - Canada 62
JP - Giappone 56
AR - Argentina 55
ID - Indonesia 52
IQ - Iraq 48
UA - Ucraina 41
TR - Turchia 40
MX - Messico 38
EC - Ecuador 36
ES - Italia 36
ZA - Sudafrica 36
PH - Filippine 34
SA - Arabia Saudita 31
TN - Tunisia 31
EG - Egitto 29
PK - Pakistan 29
MU - Mauritius 28
MA - Marocco 26
UZ - Uzbekistan 26
ET - Etiopia 24
PT - Portogallo 24
VE - Venezuela 24
PS - Palestinian Territory 23
RO - Romania 23
AZ - Azerbaigian 22
CI - Costa d'Avorio 22
CO - Colombia 22
GR - Grecia 22
NI - Nicaragua 22
PE - Perù 22
AE - Emirati Arabi Uniti 21
AT - Austria 21
MY - Malesia 21
AO - Angola 20
GT - Guatemala 20
KR - Corea 20
LC - Santa Lucia 20
BA - Bosnia-Erzegovina 19
CG - Congo 19
CL - Cile 19
HU - Ungheria 19
LA - Repubblica Popolare Democratica del Laos 19
MN - Mongolia 19
NP - Nepal 19
TH - Thailandia 19
BF - Burkina Faso 18
DZ - Algeria 18
IE - Irlanda 18
KE - Kenya 18
LB - Libano 18
NO - Norvegia 18
PY - Paraguay 18
UG - Uganda 18
YE - Yemen 18
CU - Cuba 17
DO - Repubblica Dominicana 17
GN - Guinea 17
KG - Kirghizistan 17
KZ - Kazakistan 17
MG - Madagascar 17
PA - Panama 17
TJ - Tagikistan 17
TZ - Tanzania 17
ZW - Zimbabwe 17
AL - Albania 16
GE - Georgia 16
LU - Lussemburgo 16
LY - Libia 16
ME - Montenegro 16
RW - Ruanda 16
UY - Uruguay 16
BJ - Benin 15
BZ - Belize 15
CH - Svizzera 15
IS - Islanda 15
KH - Cambogia 15
NC - Nuova Caledonia 15
SK - Slovacchia (Repubblica Slovacca) 15
TW - Taiwan 15
ZM - Zambia 15
AM - Armenia 14
BE - Belgio 14
BS - Bahamas 14
Totale 13.462
Città #
Fairfield 796
Ashburn 705
Singapore 669
San Jose 641
Woodbridge 484
Houston 351
Ann Arbor 292
Cambridge 291
Chandler 270
Seattle 269
Hong Kong 260
Wilmington 248
Bytom 141
Ho Chi Minh City 112
Santa Clara 111
Beijing 109
Milan 104
Boardman 96
Princeton 92
Hanoi 89
Los Angeles 82
San Diego 82
Lauterbourg 65
Rome 65
Medford 64
Helsinki 58
Padova 45
Jacksonville 43
Nanjing 43
Des Moines 42
New York 42
Roxbury 41
São Paulo 35
Dallas 32
Tokyo 31
Atlanta 30
Florence 30
Chicago 29
Trento 27
Bologna 26
Tashkent 24
Baku 22
Buffalo 21
Managua 21
Abidjan 20
Castries 20
Frankfurt am Main 20
Jinan 20
London 20
Naples 19
Haiphong 18
Munich 18
Vientiane 18
Conakry 17
Council Bluffs 17
Hebei 17
Kampala 17
Antananarivo 16
Guangzhou 16
Harare 16
Kigali 16
Montevideo 16
Montreal 16
Nairobi 16
Panama City 16
Shenyang 16
Ulan Bator 16
Baghdad 15
Da Nang 15
Dar es Salaam 15
Genoa 15
Havana 15
Johannesburg 15
Nanchang 15
Noumea 15
San Francisco 15
Dong Ket 14
Dublin 14
Luanda 14
Lusaka 14
Orem 14
Ouagadougou 14
Warsaw 14
Amman 13
Bishkek 13
Brasília 13
Cotonou 13
Dakar 13
Dushanbe 13
Guatemala City 13
Luxembourg 13
Nassau 13
Phnom Penh 13
Rio de Janeiro 13
San José 13
Shanghai 13
Trieste 13
Addis Ababa 12
Kingstown 12
Niamey 12
Totale 7.982
Nome #
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 669
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 641
Protocollo operativo per la verifica della comparabilità dei risultati di laboratorio ottenuti su più procedure analitiche 453
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 363
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? 295
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 256
What information on measurement uncertainty should be communicated to clinicians, and how? 251
Harmonization of pre-analytical quality indicators. 238
Quality indicators to detect pre-analytical errors in laboratory testing 234
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy 234
A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: Preliminary findings in China 222
Performance criteria and quality indicators for the pre-analytical phase. 219
Extra-analytical sources of uncertainty: which ones really matter? 214
Decision Support and Patient Safety 214
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 207
Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements 206
External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine 205
Assessment of package inserts for diagnostic kits. 203
An integrated system for monitoring the quality of sample transportation. 202
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 201
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 201
An Italian External Quality Assessment (EQA) program on urinary sediment. 199
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 199
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers 196
High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay 194
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 193
Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. 185
A rapid, specific enzyme immunoassay for follitropin and lutropin determination. 184
External quality assessment for biochemical markers of myocardial damage: an Italian experience. 183
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness 182
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: A consensus statement on behalf of the IFCC Working Group "laboratory Error and Patient Safety" and EFLM Task and Finish Group "performance specifications for the extra-analytical phases" 179
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 178
Once upon a time: A tale of ISO 15189 accreditation 172
Reference intervals: Are interlaboratory differences appropriate? 171
External quality assessment programs in the context of ISO 15189 accreditation 171
Performance specifications of critical results management 170
Evaluation of an ELISA for SARS-CoV-2 antibody testing: Clinical performances and correlation with plaque reduction neutralization titer 170
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 169
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Società Italiana di Biochimica Clinica), and SIPMeL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) 169
Quality indicators for laboratory diagnostics: consensus is needed. 164
Measurement uncertainty: Light in the shadows 164
External Quality Assessment Schemes: need for recognised requirements 163
Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs 162
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 162
Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches 160
Risk management in laboratory medicine: quality assurance programs and professional competence. 159
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy 158
Preanalytical challenges - time for solutions 158
The use of extra-analytical phase quality indicators by clinical laboratories: The results of an international survey 157
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. 157
The silk road to total quality in Laboratory Medicine 154
Effects of sample transportation on commonly requested laboratory tests. 154
Reply to W.G. Wood. Questionable results - who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 153
Harmonization of units and reference intervals of plasma proteins: State of the art from an External Quality Assessment Scheme 153
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 152
Importance of control materials in quality assessment of cyclosporine determination. 147
Quality specifications in EQA schemes: from theory to practice 147
Extra-analytical quality indicators and laboratory performances 145
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice 145
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 144
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 143
Extra-analytical quality indicators - Where to now? 143
Serological diagnostic for SARS-CoV-2: An experimental External Quality Assessment Scheme 141
Serum bone alkaline phosphatase in the follow-up of skeletal metastases. 139
Post-standardization of routine creatinine assays: are they suitable for clinical applications 138
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 136
Critical laboratory results: communication is just one of the problems. 135
Quality Indicators for the Total Testing Process 128
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 112
IFCC project “Model of quality indicators”: a method for results evaluation 109
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 104
Innovative software for recording preanalytical errors in accord with the IFCC quality indicators 102
The standardization of plasma protein checked by an external quality assessment scheme (EQAS) 102
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 99
Totale 14.181
Categoria #
all - tutte 39.511
article - articoli 35.503
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.010 0 101 158 67 23 85 59 109 45 40 110 213
2022/2023693 149 49 31 47 115 66 17 60 80 24 38 17
2023/2024474 26 41 45 45 37 30 63 22 27 17 55 66
2024/20251.639 16 106 70 79 213 34 118 113 135 68 288 399
2025/20266.355 227 564 938 1.123 569 229 631 574 619 417 254 210
2026/2027797 323 474 0 0 0 0 0 0 0 0 0 0
Totale 14.181